Atrás
Unicycive Therapeutics Inc (UNCY) Ganando
Gráfico del Precio de Acciones UNCY
UNCY Ganando
Unicycive Therapeutics Inc
$6.93
-2.66%
$-0.19
Al cierre: Apr 02, 16:00:00 GMT-4
$7
1.14%
$0.07
Mercado Posterior: Apr 02, 20:00:00 GMT-4
Estadísticas clave
Cierre Anterior
$7.12
Precio de apertura
$6.99
Rango del día
$6.76 - $7.08
Rango de 52 semanas
$3.71 - $11
Volumen
487.4K
Volumen promedio
558.2K
Rendimiento de dividendos
--
EPS (TTM)
-2.97
Cap. de mercado
$150.6M
¿Qué es UNCY?
Unicycive Therapeutics, Inc. engages in the development of treatment for kidney diseases. The company is headquartered in Los Altos, California and currently employs 22 full-time employees. The company went IPO on 2021-06-17. The firm's lead drug candidate, oxylanthanum carbonate (OLC), is an investigational phosphate binding agent being developed for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis. Its second asset, UNI-494, is a patent-protected new chemical entity in clinical development for the treatment of conditions related to acute kidney injury.
Características
Recursos
© 2026 Finture Development Limited. Todos los derechos reservados.